🟢 United Therapeutics is trading 4.1% up today after authorizing up to $2 billion in common-stock repurchases

United Therapeutics is trading at $586.62 (+4.10%) amid its announcement of a share repurchase authorization of up to $2 billion.

• The authorization covers common stock through October 21, 2027, and was announced October 22.
• Purchases are discretionary, and the report does not explicitly link the intraday gain to the news.
• Broader markets were sharply lower, suggesting the stock’s rise was company-specific rather than aligned with the market’s direction.